<DOC>
	<DOCNO>NCT02963402</DOCNO>
	<brief_summary>We speculate best responder tocilizumab multiple related element ( Treg CD39 , adenosine , IL-35 ) successfully induce express order play beneficial role . The study element pathway could help identify best responder tocilizumab treatment .</brief_summary>
	<brief_title>Immunoregulatory Mechanisms Treg Cells Induced Tocilizumab</brief_title>
	<detailed_description />
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Patients sex , age ≥ 18 year . RA Patients ( accord ACR / EULAR criterion 2010 ) moderate severe activity ( DAS 28 &gt; 3.2 SDAI &gt; 11 ) , 6 month evolution , start treatment ACTEMRA ( tocilizumab ) antiTNF , accord product data . Patients body weight ≤ 150 kg . Patients receive write information study give inform consent participate study Patients history autoimmune disease inflammatory joint disease RA . Patients treat investigational agent within 4 week ( 5 halflives investigational agent , whichever great ) start treatment tocilizumab</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>